iGalen (Emulin global rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

iGalen (Emulin global rights) General Information

Description

A portfolio of pharmaceutical based patent rights in California, United States. The portfolio comprises of rights for the patented plant-based combination for the brands Emulin, Emulin+ and GC7X.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Drug Discovery
Acquirer
Holista Colltech
Primary Office
  • San Diego, CA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

iGalen (Emulin global rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore iGalen (Emulin global rights)‘s full profile, request access.

Request a free trial

iGalen (Emulin global rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore iGalen (Emulin global rights)‘s full profile, request access.

Request a free trial